DDIT4 and pancreatic neoplasm: Our results indicated that DDIT4 had a higher expression level in poor differentiated adenocarcinoma compared to other pancreatic cancer pathological styles including the moderately differentiated adenocarcinoma, highly differentiated adenocarcinoma, and false papilloma of pancreatic cancer.